Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters  by Takahashi, Mamoru et al.
G
T
S
General Thoracic Surgery Takahashi et alTumor invasiveness as defined by the newly proposed IASLC/ATS/
ERS classification has prognostic significance for pathologic stage IA
lung adenocarcinoma and can be predicted by radiologic parametersMamoru Takahashi, MD,a Yoshiki Shigematsu, MD, PhD,a Makoto Ohta, MD,b
Hironobu Tokumasu, MD, MPH,c Tadashi Matsukura, MD, PhD,a and Takashi Hirai, MD, PhDaFrom th
Hosp
Schoo
Disclosu
Receive
public
Address
Tsuki
0022-52
Copyrig
http://dx
54Objectives: The International Association for the Study of Lung Cancer, American Thoracic Society, and
European Respiratory Society (IASLC/ATS/ERS) have collaborated to propose a new pathologic classification
of lung adenocarcinoma. In this classification, noninvasiveness and invasiveness have been newly defined for
lung adenocarcinoma. The aims of this study were to validate the prognostic significance of tumor invasiveness
as defined by the new IASLC/ATS/ERS classification and to assess the relationship between pathologic
invasiveness and radiologic findings in pathologic stage IA lung adenocarcinoma.
Methods:We retrospectively reviewed 123 consecutive patients with pathologic stage IA lung adenocarcinoma.
Pathologic data were classified according to the new IASLC/ATS/ERS classification. The following radiologic
parameters were assessed using thin-section computed tomography: the ground-glass opacity ratio, tumor
disappearance rate, and consolidation diameter.
Results: There were 54 noninvasive and 69 invasive adenocarcinomas. Five-year overall survival rates for
noninvasive adenocarcinoma and invasive adenocarcinoma were 100% and 78.4%, respectively; this difference
was statistically significant (P<.01), indicating the prognostic value of this classification. Receiver operating
characteristic curves of the ground-glass opacity ratio, tumor disappearance rate, and consolidation diameter
identified the optimal cut-off values for predicting the presence of invasive tumors as 50%, 75%, and
10 mm, respectively.
Conclusions:We found that by using the new IASLC/ATS/ERS classification, histologic subtypes of pathologic
stage IA lung adenocarcinoma with prognostic value could be identified. Tumor invasiveness of lung
adenocarcinoma as defined by this classification can be predicted by evaluating the ground-glass opacity ratio,
tumor disappearance rate, and consolidation diameter on thin-section computed tomography. (J Thorac Cardi-
ovasc Surg 2014;147:54-9)The 2004 World Health Organization classification and
the Noguchi classification are the most widely
used systems for lung adenocarcinoma.1-3 However,
rapidly evolving advances in the understanding of lung
adenocarcinoma have resulted in confusion about the
current classifications.4-6 To address this, the International
Association for the Study of Lung Cancer, American
Thoracic Society, and European Respiratory Society
(IASLC/ATS/ERS) proposed a new classification of lung
adenocarcinoma in 2011.5 Validation of the new IASLC/
ATS/ERS classification will illustrate its effect in the
clinical setting. In addition, correlation between radiologice Department of Chest Surgery,a Department of Pathology,b Fukui Red Cross
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The Journal of Thoracic and Cardiovascular Surgefindings and tumor invasiveness as defined by the new
classification will enable thoracic surgeons to select the
optimal surgical procedure. The present study had 2
purposes. First, we validated the prognostic significance
of tumor invasiveness as defined by the newly proposed
IASLC/ATS/ERS classification for pathologic stage IA
lung adenocarcinoma. Second, we clarified the relation-
ship between the radiologic findings on preoperative
thin-section computed tomography (CT) images and
tumor invasiveness according to the new IASLC/ATS/
ERS classification.
MATERIALS AND METHODS
Between January 2004 and December 2010, there were 131 patients
with preoperatively untreated stage IA adenocarcinoma who underwent
lung tumor resection with dissection or sampling of lymph nodes and
were evaluated pathologically as having stage IA (p-stage IA) adenocarci-
noma at the Fukui Red Cross Hospital.
Of these, we retrospectively evaluated a series of 123 consecutive
patients with a single stage IA adenocarcinoma. Eight patients with
multiple lung adenocarcinomas were excluded (Figure 1). All surgeries
were performed or supervised by the same surgeon (T.H.) throughout the
study period. The study included 56 men and 67 women, with a mean
age of 67 years (range, 28-85 years). The median follow-up period wasry c January 2014
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cords including preoperative images was obtained. This retrospective study
was approved by our institutional review board. All cases were assessed
according to the Union for International Cancer Control/American Joint
Committee on Cancer TNM Classification (7th ed).7 Resected specimens
were formalin-fixed and stained with hematoxylin and eosin in a routine
manner. Histologic examinations were performed according to the newly
proposed IASLC/ATS/ERS classification of lung adenocarcinoma.5
Specimens were evaluated pathologically by a single pathologist (M.O.).
The sizes of both the total tumor and the invasive component were verified
for each tumor by 2 doctors (M.O. andM.T.). In this study, adenocarcinoma
in situ (AIS) and minimally invasive adenocarcinoma (MIA) were referred
to as noninvasive adenocarcinoma, and the others types of tumors were
referred to as invasive adenocarcinoma.
Routine preoperative tests performed were as follows: chest roentgen-
ography, laboratory tests including those for serum carcinoembryonic
antigen (CEA) level, enhanced CT of the whole body, and enhanced brain
magnetic resonance imaging. Either positron emission tomography with
F-18 fluorodeoxyglucose or bone scintigraphy was performed for all
patients. Preoperative serum CEA levels were assessed using enzyme-
linked immunosorbent assay kits, with an upper limit of normal of
5.0 ng/mL.
Contrast-enhanced chest CT images were obtained using a commer-
cially available scanner (Brilliance 64 CT scanner; Philips Electronics
Japan, Tokyo, Japan). Thin-section CT images targeted to the
tumor were obtained for each patient using the following parameters:
120 kVp, 490 mA, 1-mm section thickness, and 512 3 512 pixel
resolution. The images were assessed using the mediastinal window
setting (level, 40 Hounsfield units [HU]; width, 350 HU) and the lung
window setting (level, 600 HU; width, 1500 HU). Ground-glass opacity
(GGO) was defined as a hazy increase in attenuation not associated with
obscured underlying lung structures in the lung window setting, whereas
consolidation was defined as an increase in attenuation that obscured the
underlying structures.8
In the present study, we examined 3 radiologic parameters: the GGO
ratio, tumor disappearance rate (TDR), and consolidation diameter (CD).
The GGO ratio (%) was defined as follows: (1  [maximum dimension
of consolidation on the lung window setting/maximum dimension of the
tumor on the lung window setting]) 3 100.9 The TDR (%) was defined
as follows: (1  [maximum area of consolidation on the mediastinal
window setting/maximum area of tumor on the lung windowThe Journal of Thoracic and Csetting]) 3 100.9,10 The CD (mm) was defined as the largest diameter of
consolidation on the lung window setting. Preoperative CT images were
reviewed by 2 doctors (M.T. and Y.S.) blinded to the histopathologic
status. Wide interobserver discrepancies in calculating the radiologic
parameters were resolved by consensus with a third observer. Patients
were followed up on an outpatient basis at least every 6 months to
evaluate recurrence and survival. Chest CT was performed at 6-month
intervals. Patients with recurrent disease received chemotherapy,
radiotherapy, or both as often as possible.
The survival probability was calculated using the Kaplan-Meier method
and differences in survival were evaluated using the log-rank test. Survival
was calculated from the date of surgical intervention until death from any
cause. To predict invasive adenocarcinomas defined according to the new
IASLC/ATS/ERS classification, receiver operating characteristic (ROC)
curves for the GGO ratio, TDR, and CD were generated. The optimal
cut-off points were defined as those on the curves closest to the upper
left-hand corner.11 Statistical measures and significance based on these
cut-off values were investigated using binary classification and the
chi-square test. We performed univariate logistic regression analysis to
examine the predictive value of radiologic parameters and conventional
clinical factors for pathologically invasive adenocarcinomas. Statistical
analysis was performed using SPSS version 19 (Chicago, Ill). A P value
of less than .05 was considered statistically significant.RESULTS
The clinical and pathologic characteristics of the patients
are summarized in Table 1. We detected 54 noninvasive
adenocarcinomas and 69 invasive adenocarcinomas. The
5-year overall survival rate for all patients was 88.5%
(95% confidence interval [CI], 80.8%-96.2%). Tumor
recurrences were found in 8 patients (6.5%), and in 5 cases
recurrence resulted in cancer-related deaths. No recurrence
was detected in patients with noninvasive adenocarcinomas
(lobectomy, 30; limited resection, 24). Among the patients
with noninvasive adenocarcinomas, the 5-year overall
survival rate was 100%. In contrast, the 5-year overall
survival rate was 78.4% (95% CI, 64.5%-92.2%) for
patients with invasive adenocarcinomas (lobectomy, 53;
limited resection, 16). This difference reached statistical
significance (P < .01; Figure 2), indicating possible
prognostic relevance.
The ROC curves in Figure 3 show the true-positive ratio
(sensitivity), and the false-positive ratio (1 - specificity) for
the GGO ratio, TDR, and CD to predict pathologically
invasive adenocarcinomas. The optimal cut-off values for
the GGO ratio, TDR, and CD according to the ROC curves
were 50% (area under the curve [AUC], 0.91; 95% CI,
0.86-0.97), 75% (AUC, 0.90; 95% CI, 0.84-0.96), and 10
mm (AUC, 0.91; 95% CI, 0.86-0.97), respectively. As the
AUC for each parameter approached 0.9, the cut-off values
were considered highly accurate. The relationship between
the radiologic parameters and pathologic invasiveness of
lung adenocarcinoma according to the cut-off values was
investigated (Table 2). With these cut-off values, the GGO
ratio, TDR, and CD showed positive predictive values
greater than 90%. The results of univariate analysis to
predict invasive adenocarcinoma using these cut-off valuesardiovascular Surgery c Volume 147, Number 1 55
FIGURE 1. Patient selection flow chart.
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Sand conventional clinical factors is shown in Table 3. Clin-
ically significant predictors of invasive adenocarcinoma
were the GGO ratio (50% vs>50%; P< .01), TDR
(75% vs>75%; P< .01), CD (10 mm vs>10 mm;
P< .01), tumor size (20 mm vs>20 mm; P ¼ .048),
and preoperative serum CEA level (5 ng/mL vs
>5 ng/mL; P<.01).TABLE 1. Clinicopathologic characteristics of the patients
Factor
Noninvasive
(N ¼ 54)
Invasive
(N ¼ 69)
Total
(N ¼ 123)
Sex
Male 15 41 56
Female 39 28 67
Age (y)
70 39 36 75
>70 15 33 48
Surgical procedure
Lobectomy 30 53 83
Limited resection 24 16 40
Tumor diameter (mm)
20 43 41 84
>20 11 28 39
Preoperative serum CEA level
Normal 51 50 101
Increased 3 19 22
Recurrence 0 8 8
5-y overall survival rate (%) 100 78.4 88.5
Histologic type
Adenocarcinoma in situ 27 —
Minimally invasive adenocarcinoma 27 —
Lepidic predominant — 10
Acinar predominant — 14
Papillary predominant — 30
Micropapillary predominant — 2
Solid predominant — 4
Invasive mucinous adenocarcinoma — 9
Limited resection included wedge resection and segmentectomy. N, Number of
patients; CEA, carcinoembryonic antigen.
56 The Journal of Thoracic and Cardiovascular SurgeDISCUSSION
Our results suggested 2 outcomes. First, tumor invasive-
ness as defined according to the IASLC/ATS/ERS
classification of adenocarcinoma was identified as a
significant prognostic factor for p-stage IA disease. Second,
the GGO ratio, TDR, and CD on thin-section CTwere well
correlated with tumor invasiveness and could be useful for
detecting invasive adenocarcinoma.
In the new IASLC/ATS/ERS classification, one major
transition is the discontinuation of the term ‘‘bronchioloal-
veolar carcinoma’’ (BAC). One of the reasons for this is that
the term BAC has been applied to a broad spectrum of tu-
mors, ranging from solitary small noninvasive lung adeno-
carcinomas to mixed subtype invasive adenocarcinomas.3,5FIGURE 2. Overall survival curves of patients with p-stage IA
adenocarcinoma based on tumor invasiveness proposed by the
International Association for the Study of Lung Cancer, American
Thoracic Society and European Respiratory Society. A significant
difference was noted between noninvasive adenocarcinoma and invasive
adenocarcinoma (P<.01). NRR, Number remaining at risk.
ry c January 2014
FIGURE 3. Receiver operating characteristic curves for the (A) GGO ratio, (B) TDR, and (C) CD showing the optimal cut-off values for the parameters.
AUC, Area under the curve; GGO, ground-glass opacity; TDR, tumor disappearance rate; CD, consolidation diameter.
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and MIA instead of BAC to define noninvasive
adenocarcinomas.
Our study confirmed a clear prognostic difference
between noninvasive adenocarcinoma and invasive adeno-
carcinoma as defined according to the new IASLC/ATS/
ERS classification. This finding supported the classification
system with regard to the identification of histologic
subtypes of lung adenocarcinoma with prognostic value.
In addition, no recurrences were found in noninvasive
adenocarcinomas regardless of the surgical procedures
used in the present study. AIS and MIA were suggested to
be possible candidates for limited resection because the
prognoses were excellent with complete resection in our
study and in previous reports.4,6 In fact, lung-sparing
resections have been indispensable procedures for patients
with multiple noninvasive adenocarcinomas.12-14
However, the standard surgical procedure for lung cancer
should be lobectomy and only carefully selected patients
should undergo limited resection. Therefore, preoperative
or intraoperative evaluation can be crucial in selecting
surgical procedures.The Journal of Thoracic and CGenerally, it is very difficult for pathologists to exclude
tumor invasion on the basis of an examination of a
preoperative or intraoperative frozen section.6 Thus, the
radiologic features of noninvasive and invasive adenocarci-
nomas on preoperative radiography may help determine the
most appropriate surgical procedures.
The second finding of the present study was that
thin-section CT features were well correlated with tumor
invasiveness as defined by the new IASLC/ATS/ERS
classification. Difficulty in preoperatively identifying
invasive tumors according to radiologic findings has been
highlighted in several studies.15,16 This may be because
tumor size alone is not an accurate indicator of tumor
invasiveness.15
Recently, improved understanding of the pathologic and
radiologic characteristics of small adenocarcinomas of the
lung has clarified the correlation between thin-section CT
findings and pathologic features.17-20 The lepidic growth
pattern of adenocarcinoma replacing the alveolar wall
presents a GGO appearance on thin-section CT. In contrast,
a solid tumor appearance on thin-section CT reflects a
collapse of the alveolar wall, fibrosis, and proliferation ofardiovascular Surgery c Volume 147, Number 1 57
TABLE 2. Relationship between radiologic parameters and pathologic invasiveness of lung adenocarcinoma
Radiologic parameter Noninvasive (N) Invasive (N) Sensitivity (%) Specificity (%) PPV (%) FNR (%)
Ground-glass opacity ratio
>50% 48 8 88.4 88.9 92.4 11.6
50% 6 61
Tumor disappearance rate
>75% 51 14 79.7 94.4 94.8 20.3
75% 3 55
Consolidation diameter
>10 mm 5 54 78.3 90.7 91.5 21.7
10 mm 49 15
N, Number of patients; PPV, positive predictive value; FNR, false-negative rate.
General Thoracic Surgery Takahashi et al
G
T
Sinvasive tumor cells.19 The extent of central fibrosis is
associated significantly with surgical outcomes.21,22
Persuasive data for evaluating the percentage of the GGO
component on preoperative radiography would be more
meaningful than ever before because the IASLC/ATS/
ERS have proposed new clear definitions for invasive
adenocarcinoma based on intensive analysis of a large
database. Thus, it is likely that this pathologic
classification will affect treatment strategy.6
To date, few reports have examined the relationship
between radiologic features and pathologic status based
on the new classification.2 Our data indicated that the
GGO ratio, TDR, and CD were strong indicators of tumor
invasiveness according to the IASLC/ATS/ERS classifica-
tion and that a GGO ratio of 50%, a TDR of 75%, and a
CD of 10 mm could be practical cut-off points. In fact,
previous studies have shown that a GGO ratio or a TDR
greater than 50% for small adenocarcinomas was a
favorable prognostic factor.17-20 Our data, based on the
new pathologic classification, support these results.
Although our findings indicated that all 3 parameters on
thin-section CT were fully correlated with tumor invasive-
ness, several reports have suggested that the TDR more
strongly correlated with pathologic invasiveness than the
GGO ratio.17,18 In our analysis, the GGO ratio, TDR, and
CD all were associated because tumors with a high
GGO ratio generally showed high TDR and low CD.
Thus, we recognized that comparing these parameters by
multivariate analysis would not be statistically meaningful
for predicting invasive adenocarcinoma in this situation.
Our results suggested that radiologic parameters based onTABLE 3. Univariate analysis of possible predictors for invasive adenocar
Factor Favorable Unf
Tumor size 20 mm >
Ground-glass opacity ratio >50% 
Tumor disappearance rate >75% 
Consolidation diameter 10 mm >
Preoperative serum CEA level 5 ng/mL >5
CI, Confidence interval; CEA, carcinoembryonic antigen.
58 The Journal of Thoracic and Cardiovascular SurgeGGO might be useful regardless of dimensionality,
although many radiologic parameters, such as the single
largest diameter, bidimensionality, and volume, have been
tested.2,5
Our study had several limitations. First, this study was
retrospective and selection bias should not be ignored. For
example, a greater fraction of patients with noninvasive
adenocarcinoma had limited resection compared with those
with invasive cancer. This suggests that we offered limited
resection to patients with favorable radiographic findings.
Thus, it will not be suitable to evaluate surgical indications
according to the results of the current study. Surgical
indicators for limited resection should be strictly verified
in randomized prospective studies. At present, phase III
randomized trials of standard lobectomy versus experi-
mental limited resection for small lung cancer are
ongoing in the United States (CALGB-140503) and in Japan
(JCOG 0804/WJOG4607L). Retrospective cumulative data,
including data from the present study, may be warranted
before the outcomes of these prospective studies are
confirmed in years to come. Second, the sample size was
relatively small. Nevertheless, our overall 5-year survival
data of 88.5% for p-stage IA lung adenocarcinoma were
equivalent to those of previous reports based on a larger data-
base.23,24 In the current study, all surgeries were performed
or supervised by the same surgeon and all specimens were
evaluated pathologically by the same pathologist to ensure
quality of the treatment and the pathologic examination.
Third, interobserver variability when calculating the
parameters cannot be ignored. The border of the GGO
shadow can be so obscure that estimating tumor size iscinoma
avorable Odds ratio (95% CI) P value
20 mm 2.3 (1.1-5.0) .048
50% 65.3 (20.7-207.7) <.01
75% 30.4 (10.3-89.7) <.01
10 mm 26.4 (9.8-70.8) <.01
ng/mL 6.5 (1.8-23.2) <.01
ry c January 2014
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window settings on the CT image for each observer to
minimize the possibility of measurement errors. For many
of the parameters, we applied the GGO ratio, TDR, and
CD to emphasize reproducibility and simplicity.
In conclusion, tumor invasiveness as defined according to
the IASLC/ATS/ERS classification of adenocarcinomawas a
significant prognostic factor for p-stage IA adenocarcinoma.
The GGO ratio, TDR, and CD can be useful predictors of
invasive adenocarcinoma.
The authors would like to thank Dr Toshihiko Sato, Department
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